Announced Wed, 5 Aug · 09:39 IST
Panacea Biotec gets UNICEF polio vaccine supply order worth USD 8.2 million for CY2028
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹420.40
prior close
₹424.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5-0.5-0.3+0.7-0.3-1.9-4.0-4.2-4.8-5.6————
Up moveDown movePending
AI summary
Panacea Biotec received a Letter of Award from UNICEF for supply of bivalent Oral Polio Vaccine (bOPV) in 10 and 20 dose presentations worth around USD 8.205 million (about Rs 78.24 crore) for Calendar Year 2028. This is part of an existing Long-Term Agreement running from April 2026 to March 2030, with earlier awards already covering Q2 CY2026 and CY2027. The order is from an international entity, denominated in USD, with no promoter or related party interest.
Likely market impact
Positive: Confirms continued international vaccine supply revenue and extends earnings visibility through CY2028 under existing UNICEF long-term deal.